Susan Fanayan

1.6k total citations
27 papers, 1.2k citations indexed

About

Susan Fanayan is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susan Fanayan has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susan Fanayan's work include Glycosylation and Glycoproteins Research (12 papers), Galectins and Cancer Biology (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Susan Fanayan is often cited by papers focused on Glycosylation and Glycoproteins Research (12 papers), Galectins and Cancer Biology (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Susan Fanayan collaborates with scholars based in Australia, United States and South Korea. Susan Fanayan's co-authors include William S. Hancock, Sue M. Firth, Robert C. Baxter, Manveen K. Sethi, Nicolle H. Packer, Mark S. Baker, Morten Thaysen‐Andersen, Jennifer A. Byrne, Mona Shehata and Marina Hincapie and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Accounts of Chemical Research.

In The Last Decade

Susan Fanayan

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan Fanayan Australia 22 943 239 197 195 177 27 1.2k
Gilles Freiss France 24 1.2k 1.2× 681 2.8× 157 0.8× 89 0.5× 585 3.3× 44 1.9k
Lena Kanter Sweden 20 959 1.0× 301 1.3× 71 0.4× 66 0.3× 628 3.5× 39 1.3k
Giovanni Santelli Italy 18 523 0.6× 117 0.5× 256 1.3× 37 0.2× 377 2.1× 41 1.1k
Linda S. Mulcahy United States 11 1.1k 1.1× 112 0.5× 86 0.4× 28 0.1× 492 2.8× 13 1.7k
Zhixiang Wu China 12 963 1.0× 139 0.6× 22 0.1× 145 0.7× 127 0.7× 19 1.2k
Margaret M. Centenera Australia 23 1.0k 1.1× 673 2.8× 155 0.8× 66 0.3× 519 2.9× 39 1.9k
Hayley C. Whitaker United Kingdom 22 699 0.7× 184 0.8× 84 0.4× 43 0.2× 237 1.3× 61 1.4k
Elizabeth Luis United States 15 497 0.5× 57 0.2× 112 0.6× 60 0.3× 275 1.6× 18 885
Vilde Drageset Haakensen Norway 21 761 0.8× 314 1.3× 19 0.1× 60 0.3× 330 1.9× 42 1.1k
Johannes Bange Germany 10 966 1.0× 211 0.9× 51 0.3× 17 0.1× 420 2.4× 17 1.4k

Countries citing papers authored by Susan Fanayan

Since Specialization
Citations

This map shows the geographic impact of Susan Fanayan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan Fanayan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan Fanayan more than expected).

Fields of papers citing papers by Susan Fanayan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan Fanayan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan Fanayan. The network helps show where Susan Fanayan may publish in the future.

Co-authorship network of co-authors of Susan Fanayan

This figure shows the co-authorship network connecting the top 25 collaborators of Susan Fanayan. A scholar is included among the top collaborators of Susan Fanayan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan Fanayan. Susan Fanayan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Baker, Mark S., Seong Beom Ahn, Abidali Mohamedali, et al.. (2017). Accelerating the search for the missing proteins in the human proteome. Nature Communications. 8(1). 14271–14271. 76 indexed citations
2.
Higdon, Roger, Manveen K. Sethi, Liang Lin, et al.. (2017). Integrated Proteomic and Transcriptomic-Based Approaches to Identifying Signature Biomarkers and Pathways for Elucidation of Daoy and UW228 Subtypes. Proteomes. 5(1). 5–5. 21 indexed citations
3.
Sethi, Manveen K., Hoguen Kim, Cheol Keun Park, et al.. (2015). In-depthN-glycome profiling of paired colorectal cancer and non-tumorigenic tissues reveals cancer-, stage- and EGFR-specific protein N-glycosylation. Glycobiology. 25(10). 1064–1078. 79 indexed citations
4.
Sethi, Manveen K., Morten Thaysen‐Andersen, Hoguen Kim, et al.. (2015). Quantitative proteomic analysis of paired colorectal cancer and non-tumorigenic tissues reveals signature proteins and perturbed pathways involved in CRC progression and metastasis. Journal of Proteomics. 126. 54–67. 29 indexed citations
5.
Kim, Hoguen, Seul‐Ki Jeong, Hyoung–Joo Lee, et al.. (2015). Integrated Proteomic and Genomic Analysis of Gastric Cancer Patient Tissues. Journal of Proteome Research. 14(12). 4995–5006. 6 indexed citations
6.
Sethi, Manveen K. & Susan Fanayan. (2015). Using Single Lectins to Enrich Glycoproteins in Conditioned Media. Current Protocols in Protein Science. 81(1). 24.6.1–24.6.10. 2 indexed citations
7.
Liu, Fei, Michael Koval, Shoba Ranganathan, et al.. (2015). Systems Proteomics View of the Endogenous Human Claudin Protein Family. Journal of Proteome Research. 15(2). 339–359. 28 indexed citations
8.
Lee, Ling Y., Morten Thaysen‐Andersen, Mark S. Baker, et al.. (2014). Comprehensive N-Glycome Profiling of Cultured Human Epithelial Breast Cells Identifies Unique Secretome N-Glycosylation Signatures Enabling Tumorigenic Subtype Classification. Journal of Proteome Research. 13(11). 4783–4795. 36 indexed citations
9.
Lee, Ling Y., Chi‐Hung Lin, Susan Fanayan, Nicolle H. Packer, & Morten Thaysen‐Andersen. (2014). Differential Site Accessibility Mechanistically Explains Subcellular-Specific N-Glycosylation Determinants. Frontiers in Immunology. 5. 404–404. 46 indexed citations
10.
Cristofanilli, Massimo, Fredika M. Robertson, James M. Reuben, et al.. (2013). Genome Wide Proteomics of ERBB2 and EGFR and Other Oncogenic Pathways in Inflammatory Breast Cancer. Journal of Proteome Research. 12(6). 2805–2817. 36 indexed citations
11.
Byrne, Jennifer A., Rajmohan Murali, Sanaz Maleki, et al.. (2011). 30. MAL2 and tumour protein D52 (TPD52) overexpression in ovarian carcinoma, association with histological subtype and clinical outcome. Pathology. 43. S98–S98.
12.
Madrid, Ricardo, Juan Aranda, Alejo Rodriguez-Fraticelli, et al.. (2010). The Formin INF2 Regulates Basolateral-to-Apical Transcytosis and Lumen Formation in Association with Cdc42 and MAL2. Developmental Cell. 18(5). 814–827. 73 indexed citations
13.
Byrne, Jennifer A., Sanaz Maleki, Brian Gloss, et al.. (2010). MAL2 and tumor protein D52 (TPD52) are frequently overexpressed in ovarian carcinoma, but differentially associated with histological subtype and patient outcome. BMC Cancer. 10(1). 497–497. 49 indexed citations
14.
Fanayan, Susan, et al.. (2009). Mucin 1 (MUC1) is a novel partner for MAL2 in breast carcinoma cells. BMC Cell Biology. 10(1). 7–7. 33 indexed citations
15.
Shehata, Mona, Ivan Bièche, Rose Boutros, et al.. (2008). Nonredundant Functions for Tumor Protein D52-Like Proteins Support Specific Targeting of TPD52. Clinical Cancer Research. 14(16). 5050–5060. 52 indexed citations
16.
Boutros, Rose, Susan Fanayan, Mona Shehata, & Jennifer A. Byrne. (2004). The tumor protein D52 family: many pieces, many puzzles. Biochemical and Biophysical Research Communications. 325(4). 1115–1121. 73 indexed citations
17.
Fanayan, Susan, Sue M. Firth, & Robert C. Baxter. (2002). Signaling through the Smad Pathway by Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells. Journal of Biological Chemistry. 277(9). 7255–7261. 90 indexed citations
18.
Fanayan, Susan, Sue M. Firth, Alison J. Butt, & Robert C. Baxter. (2000). Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β Receptor. Journal of Biological Chemistry. 275(50). 39146–39151. 103 indexed citations
19.
Pattison, Scott, Susan Fanayan, & Janet L. Martin. (1999). Insulin-like growth factor binding protein-3 is secreted as a phosphoprotein by human breast cancer cells. Molecular and Cellular Endocrinology. 156(1-2). 131–139. 8 indexed citations
20.
Firth, Sue M., Susan Fanayan, Diana E. Benn, & Robert C. Baxter. (1998). Development of Resistance to Insulin-like Growth Factor Binding Protein-3 in Transfected T47D Breast Cancer Cells. Biochemical and Biophysical Research Communications. 246(2). 325–329. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026